Immediate Impact

60 standout
Sub-graph 1 of 24

Citing Papers

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
1 intermediate paper

Works of Flavien Roux being referenced

Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
2015
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
2015

Author Peers

Author Last Decade Papers Cites
Flavien Roux 141 312 130 186 9 476
Michael E. Cobble 142 304 61 122 17 487
Jean-Marie Gasc 70 164 70 301 12 530
Suzanne B. Brown 120 154 103 137 9 499
Kyoko Nitta 137 207 51 244 14 574
Atsushi Shiota 64 188 32 114 13 533
Yoshihiro Yanagitani 80 118 109 119 12 548
R Dechend 95 104 51 132 11 562
Stefan Tschopp 140 311 39 295 7 572
Susumu Takagi 116 183 42 162 11 452
Kaida Ji 86 57 79 169 15 420

All Works

Loading papers...

Rankless by CCL
2026